Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by End-User & Application The global colonoscopy devices market will witness a robust CAGR of 5.1%, valued at $1.37 billion in 2021, expected to appreciate and reach $2.14 billion by 2030, confirms Strategic Market Research. Colonoscopy is an endoscopy that enables the doctor to examine the rectum and large intestine in the lowest region of the digestive tract. According to the U.S. National Library of Medicine and National Institutes of Health, every year, the United States performs nearly 11 million colonoscopies, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasonography tests, and 169,500 endoscopic retrograde cholangiopancreatography procedures. Colonoscopy is a procedure that involves inspection of the large intestine for disease, the most prevalent of which is colorectal cancer. The gastroenterologist highly recommends colorectal cancer screening for everyone over the age of 50. Some of the tests used to screen for colorectal cancer are computed tomography (C.T.) scans, rectal examination, flexible sigmoidoscopy, fecal immunochemical test (FIT), and guaiac-based fecal occult blood test (gFOBT), multitarget stool DNA screening test, and double-contrast barium enema. Moreover, during the procedure of diagnostic gastroenterology, Rectal bleeding, weight loss, abdominal pain, anemia, constipation, and diarrhea are all symptoms of gastrointestinal conditions. A gastroenterologist uses a colonoscope, a long thin, flexible tube with a tiny video camera and a light on the end, to see the whole colon, polyps, and inflammatory changes during a colonoscopy. This treatment can be used to eliminate polyps if they are discovered. This surgical removal of a polyp is known as polypectomy. However, during a colonoscopic polypectomy surgery, an electrocoagulation injury sometimes induces a transmural burn to the colon without radiographic signs of perforation, resulting in Postpolypectomy Coagulation Syndrome. Heavy bleeding, fever or chills, severe pain, or bloating in the abdomen. Vomiting and irregular heartbeats are the common complications and side effects of removing polyps. After the polyps have been removed, one can examine the inner part of the body under a microscope to determine whether it is precancerous or not. A polyp might take up to 15 years to transform into its cancerous form. Also, with the help of the procedures like Esophagogastroduodenoscopy,pouchoscopy, nuclear magnetic resonance (M.R.) scans, and virtual colonoscopy (a low-dose computed tomography (C.T.) X-ray examination of the colon), it enables the doctor to examine the polyps formed inside the colon, which can develop into colon cancer. According to the American Cancer Society, in the United States, in 2017, approximately 95,520 new cases of colon cancer and 39,910 new instances of rectal cancer were reported. Impact of Covid-19 The Covid-19 outbreak had adversely impacted the overall growth of the market. As a result, people avoiding screening and treatment to keep themselves safe from various diseases, including cancer, and the danger of catching SARS Cov-2 infection at healthcare facilities. Also, between March and June of 2020, Colon cancer screening in the United States has dropped dramatically, putting up to 18,000 patients at the risk of delayed diagnosis. However, if timely screening is not implemented, the scenario is expected to harm the cancer patients, increasing colorectal cancer mortality. Moreover, the patients undergoing colonoscopic tests are strictly restricted from using Prophylactic antibiotics. Market Drivers The continuous increase in the prevalence of colorectal cancer and the rising desire for minimally invasive procedures are among the primary drivers propelling the market expansion. The frequency of diagnostic screening methods has increased over the years for intestinal and chronic diseases such as rectal cancer, lung conditions, chronic constipation, colon cancer, inflammatory bowel disease, polyps, chronic diarrhea, rectal bleeding, ulcers, anal itching, gastrointestinal hemorrhage, and G.I. bleeding-related disorders. This rising prevalence of intestinal illnesses is expected to drive the expansion of the market. Furthermore, rising income levels, greater awareness, and frequency of colon-related disorders, particularly in the rural regions, drive the overall market expansion. Market Restraint The availability of alternative treatments for rectal disease and the risk involved with colonoscopy procedures may limit the demand for colonoscopy devices. Moreover, the market's expansion is likely to be hampered by the risk involved in the procedure, scarcity of experienced professionals, and unfavorable reimbursement regulations. Market Opportunity Due to the increased therapeutic capabilities of colonoscopy instruments, annual colonoscopy treatments are also expected to rise. Furthermore, as individuals become more aware of the consequences of colon-related problems, the global market for colonoscopy instruments is likely to rise in the future years. According to the American Cancer Society, the Alaskan natives had the highest CRC incidence (91 per 100,000) and mortality (37 per 100,000) rates in the United States. With roughly 150,000 cases reported each year in the U.S., cancer deaths from colon cancer are expected to be the third-leading cause. Market Analysis Of Different Segments Covered in the Report By Component Colonoscope Visualization Systems Others By Applications Ulcerative Colitis Lynch Syndrome Colorectal Cancer Crohn's Disease Others By End-user Hospitals And Ambulatory Surgery Centers Diagnostic Centers Clinics Regional Coverage Analysis North America United States Canada Mexico Europe Germany France Italy Switzerland United Kingdom Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA Based on the component, the colonoscope segment is expected to dominate the worldwide market with a CAGR of 4.97 % during the projected period. Based on the application, colorectal cancer holds the largest colonoscopy devices market share. Colorectal cancer arises from the inner wall of the colon and is the third leading cause of death in the United States due to malignancy. According to the World Health Organization, cases of colorectal cancer were above 1.80 million, and there were over 862000 deaths worldwide in 2018. According to the estimations, North America will be the largest market for colonoscopy devices among the global regions. Colorectal cancer and other colon-related disorders are rising in North America, driving this market's growth. Furthermore, due to the substantial increase in demand for colonoscopy devices in China and India, as the world's fastest-growing regions, Asia-Pacific is on track to grow at the fastest rate. Improvements in the hospital infrastructure and healthcare facilities have significantly increased colonoscopy procedures in these countries. In the year 2021, the colonoscopy devices market in the United States is expected to be worth US$457.4 million. China, which is considered the world's leading economy, is expected to reach a market size of US$163.2 million by 2026, representing a 6.5 % CAGR throughout the study period. Japan and Canada are the two more critical geographic markets, with 3 % and 3.4 % forecasted growth rates, respectively. Moreover, Germany is expected to expand at a CAGR of around 3% within Europe. Due to the increasing adoption and growth in the number of colonoscopy procedures, ambulatory surgical centers are likely to be the largest end-user category for the market. Furthermore, over the next few years, benefits such as cost savings, personalized attention, and a clean atmosphere will likely drive the demand for colonoscopy operations in ambulatory surgery centers. As a result, the industry for the hospital segment is expected to reach the US $1 billion by 2027, representing a compounded annual growth rate (CAGR) of 4.13 %. Colonoscopy Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 1.37 Billion The revenue forecast in 2030 USD 2.14 Billion Growth rate CAGR of approximately 5.1% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Component, By Applications, By End-user, By Region. By Component The colonoscope, Visualization Systems, Others. By Applications Ulcerative Colitis, Lynch Syndrom, Colorectal Cancer, Crohn's Disease, Others. By End-user Hospitals And Ambulatory Surgery Centers, Diagnostic Centers, Clinics. By Region North America, Europe, Asia Pacific, Asia-Pacific, LAMEA. Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles Medtronic, Fujifilm Holdings, Olympus Corporation, KARL STORZ, Endomed Systems, NA-MED, Boston Scientific, Avantis Medical Systems, HOYA Group, Getinge Group. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Global Colonoscopy Devices Market Competitive Landscape Analysis Medtronic Fujifilm Holdings Olympus Corporation KARL STORZ Endomed Systems NA-MED Boston Scientific Avantis Medical Systems HOYA Group Getinge Group Recent Developments In April 2020, Medtronic launched an AI-powered colonoscopy gadget in the United States. The FDA approved this gadget as the first medical device incorporating artificial intelligence to help doctors in the real-time diagnosis of colon abnormalities. In October 2020, Olympus launched products the PCF-HQ190 and the PCF-H190T. These products are intended to aid in identifying various ailments and enhancing treatment capacities, which is effective for gastrointestinal tract diagnosis. The Essential Colonoscopy Devices that Market Leaders Develop Name of the product Function Key Players GIF-EZ1500 video gastroscope Offers high magnification and entire focus for observational excellence Olympus Corporation ELUXEO 700 Series Colonoscopes It helps the endoscopists minimize looping during colonoscopic procedures and supports the ability to reach the cecum as quickly as possible. Fujifilm Holdings Video Endoscopes C3C13 and C3C14 Provides H.D. quality images during the colonoscopic procedures and also acts as a cost-effective video system. Endomed Systems Frequently Asked Question About This Report What is the Colonoscopy Devices Market size in 2021? The valuation for the market was $1.31 billion in 2021. Which are the prominent industry players in the global colonoscopy devices market? The top industry players in the global market are Medtronic, Fujifilm Holdings, Olympus Corporation, KARL STORZ, OLYMPUS, Endomed Systems, NA-MED, Boston Scientific, Avantis Medical Systems, HOYA Group, Getinge Group. Which geographical region is dominating the global colonoscopy devices market? The North American region is dominating the global market. Which is the dominating end-user segment in the colonoscopy devices market? The Ambulatory Surgical Centres is the leading end-user segment in the market. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689327/ https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365127/ https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2020-2022.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791134/ Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.1.2.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2021–2030 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2021–2030 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2021–2030(USD Million) 3.1.4 Market Summary Figure 10: Colonoscopy to Witness Highest CAGR in Market, By Type, During Forecast Period Figure 11: Ambulatory Surgery Centers to Witness Higher CAGR in Market for End-User Segment during Forecast Period Figure 12: Colorectal Cancer for Application to Register Highest CAGR in Market during Forecast Period Figure 13: North America to Account for Largest Share of Market In 2021 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Market Segmentation Chapter 5. Industry Outlook 5.1 Colonoscopy Devices Market Snapshot 5.2 Global Market 5.2.1 Market, 2021 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Market, by region, 2021 - 2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Market, by Type, 2021 - 2030 (USD Million) 5.5 End-User Analysis 5.5.1 Market, by End-User, 2021 - 2030 (USD Million) 5.6 Usage Segment Analysis 5.6.1 Market, by Application, 2021 - 2030 (USD Million) 5.7 By Usage Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Market PEST analysis 5.10.2 Market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Market 6.5 Ecosystem Figure 21 Market: Ecosystem Table 3 Market: Ecosystem Figure 22 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 23 Top 10 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2021 Table 5 List of Patents in Market 6.7 Trade Analysis Figure 25 Import Data for Colonoscope, By Country, 2016–2021 (USD Thousand) Table 6 Import Data for Visualization Systems, By Country, 2016–2021 (USD Thousand) Figure 26 Import Data for Others, By Country, 2016–2021 (USD Thousand) Figure 27 Export Data for Colonoscope, By Country, 2016–2021 (USD Thousand) Table 7 Export Data for Visualization Systems, By Country, 2016–2021 (USD Thousand) Figure 28 Export Data for Others, By Country, 2016–2021 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Market: Porter’s Five Forces Analysis, 2021 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2021) 6.11.2 Trends in Technology (2021-2030) Table 9 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 29: Key players market share of companies 7.2 Manufacturers Colonoscopy Devices Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2027) Table 11 Markets, By Type, 2021–2030 (USD Million) Figure 30 Markets, By Type Figure 31 Colonoscope Segment to Register Highest CAGR in Market During Forecast Period 8.3 Colonoscope 8.3.1 Colonoscope market, 2021 - 2030 (USD Million) Figure 32: Colonoscope market, 2021 - 2030 (USD Million) 8.4 Visualization Systems 8.4.1 Visualization Systems market, 2021 - 2030 (USD Million) Figure 33: Visualization Systems market, 2021 - 2030 (USD Million) 8.5 Others 8.5.1 Others market, 2021 - 2030 (USD Million) Figure 34: Others market, 2021 - 2030 (USD Million) Chapter 9. Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2027) Table 12: Market, By End-User, 2021–2030 (USD Million) Figure 35: Market, By End-User, 2021–2030 (USD Million) Figure 36: Ambulatory Surgery Centers Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals and Ambulatory Surgery Centers 9.3.1 Hospitals and Ambulatory Surgery Centers market, 2021 - 2030 (USD Million) Figure 37: Hospitals And Ambulatory Surgery Centers market, 2021 - 2030 (USD Million) 9.4 Diagnostic Centers 9.4.1 Diagnostic Centers market, 2021 - 2030 (USD Million) Figure 38: Diagnostics Centers market, 2021 - 2030 (USD Million) 9.5 Clinics 9.5.1 Clinics market, 2021 - 2030 (USD Million) Figure 39: Clinics market, 2021 - 2030 (USD Million) Chapter 10. Market: Applications Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2021-2027) Table 13: Market, By Application, 2021–2030 (USD Million) Figure 40: Market, By Application, 2021–2030 (USD Million) Figure 41: Colorectal Cancer Segment to Register Highest CAGR in Market during Forecast Period 10.3 Ulcerative Colitis 10.3.1 Ulcerative Colitis market, 2021 - 2030 (USD Million) Figure 42: Ulcerative Colitis market, 2021 - 2030 (USD Million) 10.4 Lynch Syndrome 10.4.1 Lynch Syndrome market, 2021 - 2030 (USD Million) Figure 43: Lynch Syndrome market, 2021 - 2030 (USD Million) 10.5 Colorectal Cancer 10.5.1 Colorectal Cancer market, 2021 - 2030 (USD Million) Figure 44: Colorectal Cancer market, 2021 - 2030 (USD Million) 10.6 Crohn's Disease 10.6.1 Crohn's Disease market, 2021 - 2030 (USD Million) Figure 45: Crohn's Disease market, 2021 - 2030 (USD Million) 10.7 Others 10.7.1 Others market, 2021 - 2030 (USD Million) Figure 46: Others market, 2021 - 2030 (USD Million) Chapter 11. Market: Regional Outlook 11.1 North America Figure 47: North America Market, By Revenue Forecast (2021-2027) 11.1.1 North America Market, by country, 2021 - 2030 (USD Million) Table 14: North America Market, by Country, 2021-2027 Figure 48: North America Market 11.1.2 North America Market, by Type, 2021 - 2030 (USD Million) Table15: North America Market, by Type, 2021 - 2030 (USD Million) Figure 49: North America Market, by Type, 2021 - 2030 (USD Million) 11.1.3 North America Market, by End-User, 2021 - 2030 (USD Million) Table 16: North America Market, by End-User, 2021 - 2030 (USD Million) Figure 50: North America Market, by End-User, 2021 - 2030 (USD Million) 11.1.4 North America Market, by Application, 2021 - 2030 (USD Million) Table 17: North America Market, by Application, 2021 - 2030 (USD Million) Figure 51: North America Market, by Application, 2021 - 2030 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. Market, by Type, 2021 - 2030 (USD Million) Figure 52: U.S. Market, by Type, 2021 - 2030 (USD Million) 11.1.5.2 U.S. Market, by End-User, 2021 - 2030 (USD Million) Figure 53: U.S. Market, by End-User, 2021 - 2030 (USD Million) 11.1.5.3 U.S. Market, by Application, 2021 - 2030 (USD Million) Figure 54: U.S. Market, by Application, 2021 - 2030 (USD Million) 11.1.6 Canada 11.1.6.1 Canada Market, by Type, 2021 - 2030 (USD Million) Figure 55: Canada Market, by Type, 2021 - 2030 (USD Million) 11.1.6.2 Canada Market, by End-User, 2021 - 2030 (USD Million) Figure 56: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.1.6.3 Canada Market, by Application, 2021 - 2030 (USD Million) Figure 57: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.1.6.4 Canada Market, by Application, 2021 - 2030 (USD Million) Figure 58: Canada Market, by End-User, 2021 - 2030 (USD Million) 11.2 Europe Figure 59: Europe Market, By Revenue Forecast (2021-2027) 11.2.1 Europe Market, by country, 2021 - 2030 (USD Million) Table 18: Europe Market, by country, 2021 - 2030 (USD Million) Figure 60: Europe Market, by country, 2021 - 2030 (USD Million) 11.2.2 Europe Market, by Type, 2021 - 2030 (USD Million) Table 19: Europe Market, by Type, 2021 - 2030 (USD Million) Figure 61: Europe Market, by Type, 2021 - 2030 (USD Million) 11.2.3 Europe Market, by End-User, 2021 - 2030 (USD Million) Table 20: Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 62: Europe Market, by End-User, 2021 - 2030 (USD Million) 11.2.4 Europe Market, by Application, 2021 - 2030 (USD Million) Table 21: Europe Market, by Application, 2021 - 2030 (USD Million) Figure 63: Europe Market, by Application, 2021 - 2030 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. Market, by Type, 2021 - 2030 (USD Million) Figure 64: U.K. Market, by Type, 2021 - 2030 (USD Million) 11.2.5.2 U.K. Market, by End-User, 2021 - 2030 (USD Million) Figure 65: U.K. Market, by End-User, 2021 - 2030 (USD Million) 11.2.5.3 U.K. Market, by Application, 2021 - 2030 (USD Million) Figure 66: U.K. Market, by Application, 2021 - 2030 (USD Million) 11.2.6 Germany 11.2.6.1 Germany Market, by Type, 2021 - 2030 (USD Million) Figure 67: Germany Market, by Type, 2021 - 2030 (USD Million) 11.2.6.2 Germany Market, by End-User, 2021 - 2030 (USD Million) Figure 68: Germany Market, by End-User, 2021 - 2030 (USD Million) 11.2.6.3 Germany Market, by Application, 2021 - 2030 (USD Million) Figure 69: Germany Market, by Application, 2021 - 2030 (USD Million) 11.2.7 France 11.2.7.1 France Market, by Type, 2021 - 2030 (USD Million) Figure 70: France Market, by Type, 2021 - 2030 (USD Million) 11.2.7.2 France Market, by End-User, 2021 - 2030 (USD Million) Figure 71: France Market, by End-User, 2021 - 2030 (USD Million) 11.2.7.3 France Market, by Application, 2021 - 2030 (USD Million) Figure 72: France Market, by Application, 2021 - 2030 (USD Million) 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe Market, by Type, 2021 - 2030 (USD Million) Figure 73: Rest of Europe Market, by Type, 2021 - 2030 (USD Million) 11.2.8.2 Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) Figure 74: Rest of Europe Market, by End-User, 2021 - 2030 (USD Million) 11.2.8.3 Rest of Europe Market, by Application, 2021 - 2030 (USD Million) Figure 75: Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 11.3 Asia Pacific Figure 76: Asia Pacific Market, By Revenue Forecast (2021-2027) 11.3.1 Asia Pacific Market, by country, 2021 - 2030 (USD Million) Table 22: Asia Pacific Market, by country, 2021 - 2030 (USD Million) Figure 77: Asia Pacific Market, by country, 2021 - 2030 (USD Million) 11.3.2 Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Table 23: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) Figure 78: Asia Pacific Market, by Type, 2021 - 2030 (USD Million) 11.3.3 Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Table 24: Asia Pacific Market, by End-User, 2021 - 2030 (USD Million) Figure 79 Asia Pacific Markets, by End-User, 2021 - 2030 (USD Million) 11.3.4 Asia Pacific Market, by Application, 2021 - 2030 (USD Million) Table 25: Asia Pacific Market, by Application, 2021 - 2030 (USD Million) Figure 80: Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 11.3.5 China 11.3.5.1 China Market, by Type, 2021 - 2030 (USD Million) Figure 81: China Market, by Type, 2021 - 2030 (USD Million) 11.3.5.2 China Market, by End-User, 2021 - 2030 (USD Million) Figure 82: China Market, by End-User, 2021 - 2030 (USD Million) 11.3.5.3 China Market, by Application, 2021 - 2030 (USD Million) Figure 83: China Market, by Application, 2021 - 2030 (USD Million) 11.3.6 India 11.3.6.1 India Market, by Type, 2021 - 2030 (USD Million) Figure 84: India Market, by Type, 2021 - 2030 (USD Million) 11.3.6.2 India Market, by End-User, 2021 - 2030 (USD Million) Figure 85: India Market, by End-User, 2021 - 2030 (USD Million) 11.3.6.3 India Market, by Application, 2021 - 2030 (USD Million) Figure 86: India Market, by Application, 2021 - 2030 (USD Million) 11.3.7 Japan 11.3.7.1 Japan Market, by Type, 2021 - 2030 (USD Million) Figure 87: Japan Market, by Type, 2021 - 2030 (USD Million) 11.3.7.2 Japan Market, by End-User, 2021 - 2030 (USD Million) Figure 88: Japan Market, by End-User, 2021 - 2030 (USD Million) 12.3.7.3 Japan Market, by Application, 2021 - 2030 (USD Million) Figure 89: Japan Market, by Application, 2021 - 2030 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea Market, by Type, 2021 - 2030 (USD Million) Figure 90: South Korea Market, by Type, 2021 - 2030 (USD Million) 11.3.8.2 South Korea Market, by End-User, 2021 - 2030 (USD Million) Figure 91: South Korea Market, by End-User, 2021 - 2030 (USD Million) 12.3.8.3 South Korea Market, by Application, 2021 - 2030 (USD Million) Figure 92: South Korea Market, by Application, 2021 - 2030 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) Figure 93 Rest of APAC Market, by Type, 2021 - 2030 (USD Million) 11.3.9.2 Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) Figure 94: Rest of APAC Market, by End-User, 2021 - 2030 (USD Million) 11.3.9.3 Rest of APAC Market, by Application, 2021 - 2030 (USD Million) Figure 95: Rest of APAC Market, by Application, 2021 - 2030 (USD Million) 11.4 Latin America Figure 96: Latin America Market, By Revenue Forecast (2021-2027) 11.4.1 Latin America Market, by country, 2021 - 2030 (USD Million) Table 26: Latin America Market, by country, 2021 - 2030 (USD Million) Figure 97: Latin America Market, by country, 2021 - 2030 (USD Million) 11.4.2 Latin America Market, by Type, 2021 - 2030 (USD Million) Table 27: Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 98: Latin America Market, by Type, 2021 - 2030 (USD Million) 11.4.3 Latin America Market, by End-User, 2021 - 2030 (USD Million) Table 28: Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 99: Latin America Market, by End-User, 2021 - 2030 (USD Million) 11.4.4 Latin America Market, by Application, 2021 - 2030 (USD Million) Table 29: Latin America Market, by Application, 2021 - 2030 (USD Million) Figure 100: Latin America Market, by Application, 2021 - 2030 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil Market, by Type, 2021 - 2030 (USD Million) Figure 101: Brazil Market, by Type, 2021 - 2030 (USD Million) 11.4.5.2 Brazil Market, by End-User, 2021 - 2030 (USD Million) Figure 102: Brazil Market, by End-User, 2021 - 2030 (USD Million) 11.4.5.3 Brazil Market, by Application, 2021 - 2030 (USD Million) Figure 103: Brazil Market, by Application, 2021 - 2030 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico Market, by Type, 2021 - 2030 (USD Million) Figure 104: Mexico Market, by Type, 2021 - 2030 (USD Million) 11.4.6 2 Mexico Market, by End-User, 2021 - 2030 (USD Million) Figure 105: Mexico Market, by End-User, 2021 - 2030 (USD Million) 11.4.6.3 Mexico Market, by Application, 2021 - 2030 (USD Million) Figure 106: Mexico Market, by Application, 2021 - 2030 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) Figure 107: Rest of the Latin America Market, by Type, 2021 - 2030 (USD Million) 11.4.7.2 Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) Figure 108: Rest of the Latin America Market, by End-User, 2021 - 2030 (USD Million) 11.4.7.3 Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) Figure 109: Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 11.5 MEA Figure 110: MEA Market, By Revenue Forecast (2021-2027) 11.5.1 MEA Market, by Type, 2021 - 2030 (USD Million) Figure 111: MEA Market, by Type, 2021 - 2030 (USD Million) 11.5.2 MEA Market, by End-User, 2021 - 2030 (USD Million) Figure 112: MEA Market, by End-User, 2021 - 2030 (USD Million) 11.5.3 MEA Market, by Application, 2021 - 2030 (USD Million) Figure 113: MEA Market, by Application, 2021 - 2030 (USD Million) Chapter 12. Competitive Landscape 12.1 Medtronic. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 Fujifilm Holdings. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Olympus Corporation. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 KARL STORZ. 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 Endomed Systems. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 NA-MED. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 Boston Scientific. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 Avantis Medical Systems. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 HOYA Group. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 Getinge Group. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development